ANI Pharmaceuticals, Inc. (ANIP)
81.85
+0.65
(+0.80%)
USD |
NASDAQ |
Jun 10, 16:00
81.76
-0.09
(-0.11%)
After-Hours: 20:00
ANI Pharmaceuticals Max Drawdown (5Y) : 72.96% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 72.96% |
| April 30, 2026 | 72.96% |
| March 31, 2026 | 72.96% |
| February 28, 2026 | 72.96% |
| January 31, 2026 | 72.96% |
| December 31, 2025 | 72.96% |
| November 30, 2025 | 72.96% |
| October 31, 2025 | 72.96% |
| September 30, 2025 | 72.96% |
| August 31, 2025 | 72.96% |
| July 31, 2025 | 72.96% |
| June 30, 2025 | 72.96% |
| May 31, 2025 | 72.96% |
| April 30, 2025 | 72.96% |
| March 31, 2025 | 72.96% |
| February 28, 2025 | 72.96% |
| January 31, 2025 | 72.96% |
| December 31, 2024 | 72.96% |
| November 30, 2024 | 72.96% |
| October 31, 2024 | 72.96% |
| September 30, 2024 | 72.96% |
| August 31, 2024 | 72.96% |
| July 31, 2024 | 72.96% |
| June 30, 2024 | 72.96% |
| May 31, 2024 | 72.96% |
| Date | Value |
|---|---|
| April 30, 2024 | 72.96% |
| March 31, 2024 | 72.96% |
| February 29, 2024 | 72.96% |
| January 31, 2024 | 72.96% |
| December 31, 2023 | 72.96% |
| November 30, 2023 | 72.96% |
| October 31, 2023 | 72.96% |
| September 30, 2023 | 72.96% |
| August 31, 2023 | 72.96% |
| July 31, 2023 | 72.96% |
| June 30, 2023 | 72.96% |
| May 31, 2023 | 72.96% |
| April 30, 2023 | 72.96% |
| March 31, 2023 | 72.96% |
| February 28, 2023 | 72.96% |
| January 31, 2023 | 72.96% |
| December 31, 2022 | 72.96% |
| November 30, 2022 | 72.96% |
| October 31, 2022 | 72.96% |
| September 30, 2022 | 72.96% |
| August 31, 2022 | 72.96% |
| July 31, 2022 | 72.96% |
| June 30, 2022 | 72.96% |
| May 31, 2022 | 72.26% |
| April 30, 2022 | 72.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Indivior Pharmaceuticals, Inc. | 96.00% |
| Liquidia Corp. | 93.87% |
| Phathom Pharmaceuticals, Inc. | 95.81% |
| Catalyst Pharmaceuticals, Inc. | 45.37% |
| AbbVie, Inc. | 21.89% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 9.792 |
| Beta (5Y) | 0.4385 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.77% |
| Historical Sharpe Ratio (5Y) | 0.3378 |
| Historical Sortino (5Y) | 0.6968 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.76% |